CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

Ann: FDA agrees on potential regulatory pathway f, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. rabiez
    593 Posts.
    clock Created with Sketch.
    14/07/10
    10:13
    Post #: 6900393
    re: Ann: FDA agrees on potential regulatory p... The usual wording that does not inspire confidence "potential regulatory path to progress OMAPRO"

    and the timeline only for the patient: "we plan to submit our new NDA to the FDA by the end of the year" Seeing is believing
    CXS Price at posting: 34.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.